期刊文献+

盐酸埃他卡林扩血管特征的研究 被引量:3

Vasodilating characteristics of iptakalim hydrochloride
下载PDF
导出
摘要 目的 观察新型抗高血压药盐酸埃他卡林对大、小动脉扩张作用的药理学特征。方法 采用大鼠主动脉离体血管环和尾动脉螺旋状血管条两种组织来对比分析盐酸埃他卡林的扩血管作用。结果 盐酸埃他卡林在 10 -7~ 10 -3 mol/L范围内对氯化钾预致收缩的大鼠尾动脉血管条产生剂量依赖性舒张反应 ,且具有部分内皮依赖性 ,但对主动脉离体血管环无明显的舒张反应 ,该作用在高血压状态时显著增强 ,能被ATP敏感性钾通道特异性阻断剂格列苯脲阻断。结论 盐酸埃他卡林具有选择性舒张小动脉的作用 ,该作用与其激活ATP敏感性钾通道有关。 Objective To observe the pharmacological characteristics of a novel antihypertensive drug iptakalim hydrochloride (Ipt) by dilating large and small arteries. Methods The vasodilating action of Ipt was studied using isolated rat tail artery helical strips and aortic rings. Results The vasodilating action of Ipt at 10 7-10 3mol/L was observed in rat tail artery strips precontracted with potassium chloride (KCl) in a concentration and endothelium dependent manner, but no significant vasodilating effect was seen on rat aortic rings. Ipt-induced relaxation in tail artery was significantly greater in spontaneous hypertensive rats than that in normotensive rats. The vasodilating actions of Ipt in small arteries could be markedly antagonized by glibenclamide, an inhibitor of ATP-sensitive potassium channels. Conclusion The results suggest that iptakalim hydrochloride has a selective vasodilating action in small arteries, and the action is related to activation of ATP-sensitive potassium channels.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2004年第2期116-119,共4页 Medical Journal of Chinese People's Liberation Army
基金 国家"8 63"计划重大专项课题资助项目 (编号 2 0 0 2AA2Z31 37)
关键词 盐酸埃他卡林 腺苷三磷酸 钾通道 小动脉 主动脉 iptakalim hydrochloride adenosine triphosphate potassium channels arterioles aorta
  • 相关文献

参考文献2

二级参考文献10

  • 1娄建石,张海波,刘艳霞,朱险峰,张才丽.无创性心功能血流动力学计算机实时监测系统[J].中国药理学通报,1996,12(1):91-95. 被引量:8
  • 2[1]Furchgott R F, Zawadzki J V. The obligatory role of endothelial cells in the relaxation of arterial smooth mucle by acetylcholine[J]. Nature,1980,288:373-376.
  • 3[2]Shan L M, Wang H. Pharmacological characteristics of endothelial target for acetylcholine induced vascular relaxation[J]. Life Sciences, 2002,70:1285-1298.
  • 4[3]Palmer R M J, Ferrige A G, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor[J]. Nature,1987,327:524-526.
  • 5[4]Maulik N, Engelman D T, Watanabe M. Nitric oxide/carbon monoxide.A molecular switch for myocardial preservation during ischemia[J]. Circulation,1996,94(Suppl.Ⅱ):398-406.
  • 6[5]Dong H, Waldron G J, Cole W C, et al. Role of calcium-activated and voltage-gated delayed rectifier potassium channels in endothelium-dependent vasorelaxation of the rabbit middle cerebral artery[J]. Br J Pharmacol,1998,123:821-832.
  • 7[6]Ding H,Triggle C R. Novel endothelium-derived relaxing factors identification of factors and cellular targets[J]. J Pharmacol Toxicol Methods,2000,44(2):441-452.
  • 8刘蔚,龙超良,路新强,肖文彬,汪海.盐酸埃他卡林对大鼠离体工作心脏功能的影响[J].中国药理学通报,2002,18(3):349-351. 被引量:14
  • 9龙超良,冯华松,汪海.盐酸埃他卡林对高血压心脏重构的作用[J].中国药理学通报,2003,19(1):48-52. 被引量:22
  • 10龙超良,肖文彬,汪海.盐酸埃他卡林的降压作用及对高血压血管重构的影响[J].高血压杂志,2003,11(3):248-250. 被引量:25

共引文献20

同被引文献48

  • 1汪海,龙超良,贾国栋,何华美,解卫平,冯华松,胡刚,刘国树.盐酸埃他卡林对内皮素系统的影响[J].中国药理学通报,2005,21(1):33-38. 被引量:11
  • 2陈玉萍,崔文玉,汪海.埃他卡林对K_(ATP)通道亚型选择性作用的研究[J].中国药理学通报,2006,22(3):278-284. 被引量:11
  • 3Noma A. ATP-regulated K^+ channels in cardiac muscle [ J ]. Nature, 1983,305 (5930) : 147 - 8.
  • 4Seino S, Miki T. Physiological and pathophysiological roles of ATP-sensitive K^+ channels[ J]. Prog Biophys Mol Biol, 2003,81 : 133 -76.
  • 5Grover G J, Garlid K D. ATP-Sensitive Potassium Channels: A Review of their Cardioprotective Pharmacology[ J]. J Mol Cell Cardiol, 2000,32(4) :677 -95.
  • 6Rodrigo G C, Standen N B. ATP-sensitive potassium channels [ J ]. Curr Pharm Design, 2005,11 ( 15 ) : 1915 - 40.
  • 7Wickenden A D. K^+ channels as therapeutic drug targets [ J]. Pharmacol Ther, 2002,94 : 157 - 82.
  • 8Edwards G, Weston A H. Recent advances in the pharmacology and therapeutic potential of potassium channel openers [ J ]. Exp Opin Invest Drugs, 1996,5 : 1453 - 64.
  • 9Aguilar-Bryan L, Nichols C G, Wechsler S W, et al. Cloning of the βcell high-affinity sulfonylurea receptor: A regulator of insulin secretion [ J ]. Science, 1995,268:423 - 6.
  • 10Liss B, Bruns R, Roeper J. Alternative sulfonylurea receptor expression defines metabolic sensitivity of KATP channels in dopaminergic midbrain neurons[ J]. EMBO J, 1999,18:833 - 46.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部